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Abstract
Purpose and methods: In order to evaluate the rate of missed diagnoses (MD) of tumors in critically ill patients
died in our Intensive Care Unit (ICU) and correlate them with the outcome, all the autopsy records from January 1st,
1996 and December 31st, 2014 have been reviewed. When the tumor was not diagnosed during the admission but
discovered only at the post-mortem examination, the effect of the MD on the outcome was classified according to
the Goldman’s criteria.
Results: A total of, 1045 autopsies were examined; a solid or hematological cancer was discovered in 74 cases
(7%, 50 M, 24 F, age 75.5, IQR 29-90 years). Major discrepancies occurred in 42 patients, but only in one of them
(2.4%) a class 1 error was identified; in the other cases the MD did not influence the outcome (class 2 errors) due to
the underlying conditions determining the ICU admission and/or the very short length of stay in the ICU; for another
32 patients the MD were considered without clinical relevance.
Conclusions: In our experience, autopsy remains an extremely valuable tool to detect MD and to improve the
clinical and diagnostic procedures.
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Introduction
Several studies demonstrated that the rate of diagnostic
discrepancies discovered at the autopsy is still high in patients dying
both in the regular wards and in the Intensive Care Unit (ICU),
ranging from 5 to 40% and from 7 to 32%, respectively [1]. Despite a
worldwide decrease in their numbers, which started several decades
ago, autopsies represent a valuable tool to improve the clinical practice
primarily by enlightening possible breakdowns of the diagnostic
procedures and/or a wrong interpretation of the available informations
[2,3]. This particularly applies to ICU patients who are at risk of
missed diagnosis (MD) primarily because of the relative lack of
specificity of symptoms such as fever, tachycardia, arterial hypotension
and disturbances of the consciousness; moreover, the often rapidly
evolving clinical course can prevent clinicians from a diagnostic work-
up not immediately targeted on the life-threatening conditions
requiring the admission. A number of investigations demonstrated
that infections and cardio-respiratory diseases, including pulmonary
embolisms and myocardial infarctions account for a substantial rate of
MD in this population, with variable effects on the outcome ranging
from negligible to substantially deadly [1,4-7]. Although the
occurrence of autopsy-discovered malignancies is less common [8], yet
they can represent as many as 10% of cases [9,10] in patients admitted
for reasons other than tumors. However, independently from their rate
of occurrence, the ante-mortem diagnosis of neoplastic diseases in
critically ill patients appears relevant for two opposite reasons. On one
hand, it could identify acutely ill patients admitted to the ICU who
might take some advantage from anti-tumor treatments once the acute
phase is over [11]; actually, Taccone et al. [12] demonstrated that the
outcome of critically ill patients with already diagnosed solid cancer is
similar to that of subjects without cancer.
On the other hand, it could prevent the implementation of costly
life-extending procedures which often are associated with heavy side
effects but which are devoid of any significant effect on the survival of
patients with more advanced and/or metastatic forms, thus leaving
space to palliative therapies.
We reviewed both the autopsy and the clinical records of all patients
died in our ICU with the double aim (a) to identify the patients died in
our ICU in whom a neoplastic disease was discovered only at the post-
mortem examination; and (b) to correlate this MD with the outcome.
Patients and Methods
We retrospectively reviewed the autopsy records of the patients dead
in our 13-bed general ICU between January 1st, 1996 and December
31st, 2014. The consent of the local ethical committee was deemed
unnecessary because the study was retrospective, did not imply any
intervention and the privacy was secured. Our medical-surgical ICU is
located inside a 750-bed university hospital, admits about 1000
patients/year coming both from the emergency department and from
the regular wards, and has a 23% mortality rate.
For our study we did not adopted any selection criteria. We did not
include in the study (a) patients dying in the coronary care unit or
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cardiac surgery ICU because they are treated in other wards; (b)
obstetric and pediatric patients, as they are treated in another hospital;
and (c) patients who died after trauma because, according to the
current Italian Law, legal autopsy findings cannot be disclosed to the
physicians in charge.
All patients were intubated and mechanically ventilated throughout
their ICU admission; sepsis and sepsis-related conditions, including
severe sepsis and septic shock, were treated according to the current
guidelines [13]. All patients with cardiac arrest were admitted directly
from the ER.
The university hospital in which our ICU is situated has an autopsy
rate of 48%, which remained stable over the past two decades. The
autopsies were performed by a single experienced pathologist with a
peculiar expertise in critically ill patients (RB).
All the autoptical records were screened and when a solid or
hematologic tumor was found, the relative discharge diagnosis was
cross-checked; when the neoplasm was not mentioned, the
corresponding medical record was retrieved and a number of data
were collected, including (a) all the relevant personal and clinical
informations including age, gender, history, cause of admission, length
of stay in ICU (LOSICU), SOFA score the day of admission and the
radiologic investigations performed; and (b) the type and location of
the tumor discovered at the autopsy.
Each positive case was discussed by all the authors and the MD were
classified according the Goldman’s criteria in [14]: major MD with or
without effects on the management and the outcome are included in
Class 1 and 2, respectively, whereas Class 3 and 4 are minor MD (Table
1).
Category Class Definitions
Major
Discrepancies
1 A correct diagnosis and treatment could have
changed the outcome
2 A correct diagnosis and treatment could NOT have
changed the outcome
Minor
Discrepancy
3 Missed terminal disease unrelated with the cause of
death
4 Other missed diagnosis unrelated to death
No
discrepancies
5 No missed diagnosis
Not
classifiable
6 Patients dead immediately after the admission,
diagnostic workup incomplete or absent, autopsy
inconclusive
Table 1: Classification of diagnostic discrepancies according to their
effect on the outcome.
We used the free software R for statistical analysis (R Development
Core Team, R Foundation for Statistical computing, Vienna, Austria
2008). The statistical analysis was performed with the Fisher’s exact t-
test; a p<0.05 was considered statistically significant.
Results
In the considered period, 1045 autopsies were performed on
patients died in our ICU (Figure 1).
Figure 1: Distribution of tumors.
Overall, a solid or hematologic cancer was discovered in 74 patients
(7.0%, 50 M, 24 F, age 75.5, IQR 29-90 years). In no case a suspected
diagnosis of tumor was reported on the medical records of the wards
where patients were initially admitted. Albeit virtually every organ and
system was involved, the missed solid tumors were located prevalently
in the lung, digestive tract, prostate and kidney. During autopsy, in the
29.7% of patients with solid tumor were found a regional lymph nodes
involvement and distant metastasis; regarding the hematologic cancers,
in the 63.6% of cases were found an infiltration and invasion of the
bone marrow, spleen, liver and lymph nodes. Patients with MD were
subdivided into seven categories according to the causes of ICU
admission. Overall, the rate of major MD was 58% for patients
admitted due to respiratory failure, 83% for severe sepsis/septic shock,
38% for postoperative complications, 45% for haemorrhagic/
cardiogenic shock, 71% for cardiac arrest and none for intra-cerebral
hemorrhage (Figure 2).
Figure 2: Causes of ICU admission. Y-axis: no. of patients.
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The autoptical results, class of MD, radiological investigations and
findings and LOSICU are reported separately for each category apart
cerebral hemorrhage for which no major MD were found (Table 2).
Goldman’s
class
Category Total
no.
Solid
tumors
Hematological
tumors
Multiple
tumors
1 Major MD 1 1 0 0
2 41 30 9 2
3 Minor MD 32 30 0 2
4 0 0 0 0
Table 2: Impact of MD (missed diagnoses) of tumor on the outcome.
Forty-five patients (61%) had a LOSICU<24 hours; their distribution
is uneven, ranging from 37% of those admitted for respiratory failure
to 100% of those admitted for haemorrhagic or cardiogenic shock. Two
patients (10%) admitted for respiratory failure, other two (17%) of
those admitted for severe sepsis or septic shock and one admitted for
intra-cerebral hemorrhage had a LOSICU>14 days.
We identified a Class 1 MD in one case (2.4%). In the other cases
the severity of the conditions determining the ICU admission and/or
the short LOSICU justified both the poor outcome and the lack of a
more in-depth diagnostic workup; other MD had no relationship with
the clinical course or constituted only incidental findings (Tables 3 and
4).
No. Cancer Histological type Radiologic
investigations
Radiologic findings Goldman’s
class
LOSICU SOFA score
(1st day)
1 Lung Adenocarcinoma CRX Negative 2 5 days 11
2 Bladder Urothelial carcinoma CT abdomen Negative 3 12 days 10
3 Thyroid Papillary carcinoma Head and Neck CT Enlarged laterocervical
nodes
3 8 days 8
4 Lung Adenocarcinoma CRX ARDS 2 11 days 5
5 Lymphoma T-cell lymphoma CRX,
abdominal US
Negative 2 <24 hours 10
6 Colon Adenocarcinoma CT abdomen Negative 3 <24 hours 16
7 Lymphoma B-cell non Hodgkin lymphoma CRX Negative 2 5 days 5
8 Lung Adenocarcinoma CRX Single pulmonary opacity 2 11 days 4
9 Stomach Adenocarcinoma CRX Negative 2 1 day 9
10 Colon-prostate Both adenocarcinoma CRX Negative 3 <24 hours 9
11 Lung Adenocarcinoma CRX Mediastinal widening 2 1 day 12
12 Colon Adenocarcinoma Abdominal US Negative 3 <24 hours 8
13 Lung Adenocarcinoma CRX Single pulmonary opacity 1 53 days 5
14 Lung Adenocarcinoma CRX Pleural effusion 2 <24 hours 9
15 Lung Adenocarcinoma None N.A. 2 <24 hours 5
16 Kidney Renal cell carcinoma Abdominal US Negative 3 5 days 3
17 Pancreas Adenocarcinoma CRX Right lung opacity/ARDS 2 <24 hours 11
18 Kidney Renal cell carcinoma CRX ARDS 3 10 days 10
19 Thyroid Papillary carcinoma CRX Multiple lung opacities 3 30 days 9
Table 3: Radiologic investigations, LOSICU, and postmortem findings in patients admitted due to respiratory failure. Legend: CRX: plain chest X-
ray; US: ultrasonography; ARDS: acute respiratory distress syndrome; N.A.: not applicable.
No. Cancer Histological type Radiologicinvestigations
Radiologic
findings
Goldman’s
class LOSICU
SOFA score
(1st day)
1 Leukemia AML CRX Negative 2 <24 hours 12
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2 Lung Adenocarcinoma Lung CT Massive pulmonaryopacity 2 <24 hours 5
3 Thyroid Papillary carcinoma CRX, abdominal CT Negative 3 22 days 9
4 Pancreas Adenocarcinoma Abdominal US Negative 2 <24 hours 12
5 Stomach andpancreas Mucinous adenocarcinoma
CRX, abdominal
and lung CT Negative 2 5 days 10
6 Leukemia AML Abdominal and lungCT Negative 2 <24 hours 10
7 Leukemia AML RX, abdominal CT Negative 2 <24 hours 15
8 Biliary tract Cholangiocarcinoma Percutaneouscolangiography Negative 2 20 days 6
9 Colon andrectum Adenocarcinoma CRX Negative 3 6 days 3
10 Leukemia AML None N.A. 2 <24 hours 9
11 Leukemia ALL CRX Negative 2 <24 hours 15
12 Liver Hepatocellular carcinoma Abdominal CT Liver infarction 2 <24 hours 13
Table 4: Radiologic investigations and findings, LOSICU, and postmortem findings in patients admitted due to severe sepsis and septic shock.
Legend: CRX: plain chest X-ray; US: ultrasonography; N.A. not applicable.
Discussion
There is an on-going debate between supporters of autopsy and
others who consider the post mortem investigation somehow outdated.
The former advocate its use mainly to verify the overall diagnostic and
therapeutic appropriateness and thus to reduce avoidable deaths by
identifying MD which could have influence negatively the outcome
both in patients died in the regular wards and in the ICU [14-16,9],
whereas the latter claim that its value is reduced, but not totally
abolished, in the era of unrelenting advances of the imaging techniques
[17,18]. Besides these, in the past years other factors contributed to
determine a worldwide decrease in the rate of autopsies in patients
died in the hospital, including poor training of pathologists in its
execution, costs and the fear of litigation (Table 5-7) [19,20].
No. Cancer Histological type Radiologicinvestigations
Radiologic
findings
Goldman’s
class LOSICU
SOFA score
(1st day)
1 Kidney Renal cell carcinoma Abdominal CT Negative 3 <24 hours 10
2 Kidney Renal cell carcinoma Abdominal CT Benign renal cyst 3 5 days 10
3 Pancreas Mucinous adenocarcinoma Abdominal CT Pancreatic pseudo cyst/abscess 2 <24 hours 6
4 Kidney Renal cell carcinoma Head CT Negative 3 5 days 7
5 Stomach Mucinous adenocarcinoma CRX Negative 2 <24 hours 10
6 Colon rectum Adenocarcinoma Abdominal CT Negative 3 4 days 15
7 Colon rectum Adenocarcinoma CRX Negative 2 3 days 9
8 Colon rectum Adenocarcinoma None N.A. 3 <24 hours 4
9 Kidney Renal cell carcinoma Abdominal CT Benign renal cyst 3 12 days 9
10 Uterus ovary Adenocarcinoma CRX Negative 3 <24 hours 4
11 Colon rectum Adenocarcinoma Abdominal CT Negative 2 <24 hours 7
12 Lung Biphasic blastoma CRX Negative 3 <24 hours 16
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13 Lung Squamous cell carcinoma CRX Negative 2 <24 hours 4
Table 5: Radiologic investigations and findings, LOSICU, and autopsy results in patients admitted for postoperative complications. Legend: CRX:
plain chest X-ray; N.A. not applicable.
Hemorrhagic shock No. Cancer Histological
type
Radiologic
investigations
Radiologic
findings
Goldman’s
class
LOSICU SOFA score
(1st day)
1 Kidney Renal cell
carcinoma
None N.A. 3 <24 hours 5
2 Leukemia, lung AML, Squamous
cell carcinoma
None N.A. 2 <24 hours 5
3 Leukemia AML None N.A. 2 <24 hours 14
4 Prostate Adenocarcinoma None N.A. 2 <24 hours 15
5 Liver Hepatocellular
carcinoma
CRX Negative 2 <24 hours 7
Cardiogenic shock 6 Adrenal gland Adenocarcinoma None N.A. 3 <24 hours 5
7 Prostate Adenocarcinoma None N.A. 3 <24 hours 12
8 Stomach Adenocarcinoma EGDS Negative 3 <24 hours 7
9 Uterus, ovary Adenocarcinoma None N.A. 3 <24 hours 6
10 Colon, rectum Adenocarcinoma None N.A. 3 <24 hours 6
11 Liver Hepatocellular
carcinoma
EGDS Negative 2 <24 hours 7
Table 6: Radiologic investigations, LOSICU, and postmortem findings in patients admitted due to hemorrhagic and cardiogenic shock. Legend:
CRX: chest X-ray; EGDS. Esophagogastroduodenalscopy, N.A. not applicable.
No. Cancer Histological type Radiologic
investigations
Radiologic
findings
Goldman’s
class
LOSICU SOFA score
(1st day)
1 Colon rectum Adenocarcinoma None N.A. 2 <24 hours 6
2 Lung. Myeloma Neuroendocrine cell carcinoma,
myeloma
CRX Pulmonary opacity
(pneumonia?)
3 5 days 7
3 Colon rectum Adenocarcinoma None N.A. 2 <24 hours 9
4 Lung Adenocarcinoma Lung CT Pulmonary abscess 2 2 days 14
5 Leukemia AML CRX, lung CT Negative 2 7 days 4
6 Kidney Renal cell carcinoma None N.A. 3 <24 hours 10
7 Lung Adenocarcinoma CRX Pulmonary opacity
(pneumonia)
2 <24 hours 7
8 Liver, colon
rectum
Hepatocellular carcinoma,
adenocarcinoma
CRX Negative 2 <24 hours 7
9 Colon rectum Adenocarcinoma CRX, abdominal CT Negative 2 11 days 5
10 Pancreas Adenocarcinoma None N.A. 2 <24 hours 3
11 Colon Adenocarcinoma None N.A. 2 <24 hours 7
12 Prostate Adenocarcinoma CRX Negative 3 3 days 10
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13 Prostate Adenocarcinoma CRX Negative 3 <24 hours 3
14 Prostate Adenocarcinoma Abdominal RX Negative 2 <24 hours 2
Table 7: Radiologic investigations, LOSICU, and postmortem findings in patients admitted due to cardiac arrest. Legend: CRX: chest X-ray; N.A.
not applicable.
Actually, even if some investigators demonstrated that in patients
admitted to regular wards the occurrence of major MD decreased
along two or three decades [21,22], other studies showed that in
patients died in the ICU the rate of potentially treatable conditions
escaping to the clinical and radiologic investigations remains relatively
high primarily because of the elevated lack of specificity of the
symptoms prompting the ICU admission and to the rapidly evolving
clinical conditions [1,9]. Moreover, it is likely that the already
compromised conditions of critically ill patients could amplify the
effects of some MD making them more vulnerable [23]. Although
several investigations have been dedicated to the MD in patients died
with already diagnosed malignancies [24,25] the issue of neoplastic
diseases discovered only during the autopsy in ICU patients admitted
for other reasons has not been specifically addressed. Yet we guess that
this topic is relevant for a number of reasons, including the ever-
advancing age of critically ill patients with the subsequent risk of
underlying tumors, their prolonged LOSICU [26] and the need for a
correct triage aimed to restrict aggressive life-sustaining treatments to
neoplastic patients who could realistically take advantage from them.
Our findings deserve some remarks
First, the overall rate of MD of tumors varies among different
studies, ranging from<4% to 50% of the autopsies performed in
patients died either in regular wards and in ICU [8,9,27]; it is arguable
that our relatively low rate of MD could be at least partly related to the
above-enlisted exclusion criteria which impeded us to know the results
of the autopsies performed in other categories of critically ill patients.
Second, the Goldman’s classification is extremely useful but it does
not take into consideration the length of stay, which is a rather
important variable especially in patients with rapidly deteriorating
conditions like many of those admitted in the ICU; as an example, by
excluding patients with a LOSICU ≤ 24 hours from our study, the rate of
MD of tumors would be almost halved (4%): actually, it is likely that in
these cases the extremely brief LOSICU limited the diagnostic workup
to those life-threatening conditions responsible of the admission. On
the other hand, a prolonged LOS did not guarantee against the
presence of major MD, as they were encountered also in chronic
critically ill patients whose LOSICU exceeded two weeks.
Third, as far as the site of tumor is concerned, our results partly
differ from that those reported by Grinberg et al. [28] who observed a
similar rate of lung cancers but higher ones of pancreatic and liver
cancers; however, dissimilarly from the overall distribution of tumors
which approaches that recorded in Italy with an elevated incidence of
lung, colon and prostate tumors [29], no case of breast cancer was
observed in female patients; we hypothesize that this finding could be
primarily attributable to the widespread campaigns of screening
initiated many years ago and are actively on-going.
Fourth, the MD of lung cancer occurred notwithstanding virtually
every patient with a LOSICU>24 hours and many of those with a
LOSICU below this threshold underwent one or more chest radiograph
(CRX) or chest CT scan due to the cause of ICU admission or to
conditions occurred thereafter. Actually, despite the advances of the
techniques, all radiological investigations have some inherent
limitations: as far as the sensitivity of CRX outside the ICU is
concerned, some investigators demonstrated that as many as 19% of
early lung cancer are missed with the chest radiograph [30,31]; also the
chest CT-scan is not flawless: Wichmann et al. [32] compared
conventional vs. CT autopsies and demonstrated that, albeit medical
autopsies are less sensitive to detect traumatic injuries, the opposite
occurs for cancer. Other circumstances can further complicate the
diagnosis in critically ill mechanically ventilated patients: actually,
despite its widespread use, in ICU patients the CRX appears
particularly at risk of misinterpretation since it is usually obtained with
mobile radiographic devices in the frontal view, whereas the lateral
view can enlighten abnormalities unrecognizable when only the
anteroposterior film is achieved [30]. Moreover, with both the CRX
and the CT scan the lung cancers can be misdiagnosed with different
radiologic abnormalities more commonly encountered in mechanically
ventilated critically ill patients, including pneumonia, ARDS and
pleural effusions which can cover or mask the underlying neoplasm
[33,34].
Fifth, we did not measure the blood concentration of specific tumor
markers, including the α-fetoprotein, the carcino-embrional antigen
etc. because their blood value by itself is not a specific or sensible
indicator of tumor; moreover, in critically ill patients their elevation
can be ascribed to factors other than neoplasms such as the systemic
inflammatory response syndrome or sepsis and sepsis-derived
conditions which affected most if not all the ICU patients [35]; the
same consideration applies for the measurement of the mediators of
inflammation, including the C-reactive protein and procalcitonin,
although their elevation has been advocated as an early marker of still
asymptomatic neoplasms [36]; actually, they were repeatedly measured
during the LOSICU, and resulted constantly altered most likely due to
the presence of infections and other conditions associate with the
release of pro-inflammatory substances [37,38].
Sixth, in one case only the MD of lung tumor was considered a Class
1 error as it occurred in a patients with a prolonged LOSICU which
should have prompted more in-depth clinical investigations; the other
major discrepancies observed have been considered belonging to the
Class 2 as they occurred in patients whose coexistent conditions
leading to the ICU admission were so critical that a correct diagnosis
and treatment of tumor could not have changed the outcome and/or
the LOSICU has been extremely brief ; in the other cases the MD was
considered unrelated to the cause of death and thus categorized as
Class 3 and 4 errors. We are aware that this finding is in contrast with
the rate of 8% of Class 1 errors reported by a recent meta-analysis but
these major MD consists primarily in acute cardiac and respiratory
conditions and not by tumors such as in the current study [39].
It is arguable that if some patients with Class 2 errors would have
been discharged alive from the ICU further investigations performed
in the admitting ward would have been able to identify the tumor.
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Finally, independently from the continuous advances in the clinical
and radiological investigations, MD still represents an entity hard to
eliminate especially in patients, such as those admitted to the ICU,
whose symptoms can be interpreted in many ways, ascribed to a
number of different conditions and/or are rapidly evolving. In these
circumstances, in our as well as in other’s experience, autopsy remain
an essential tool either to verify the appropriateness of the procedures
and to recognize the limitations of other diagnostic tools.
Conclusions
In patients died in our ICU for reasons other than a neoplastic
disease, a solid or hematologic cancer was found in 7% of cases; 57% of
these MD were classified as a major discrepancy. Although 61% of
these subjects had short LOSICU, major MD were found even in
patients with chronic critical diseases.
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